Your browser doesn't support javascript.
loading
Stathmin is a potential therapeutic target but not a prognostic marker in melanoma: an immunohistochemical study of 323 melanocytic lesions.
Dundr, Pavel; Simon, Karol; Nemejcová, Kristýna; Bártu, Michaela; Tichá, Ivana; Michálková, Romana; Jaksa, Radek; Vecková, Zuzana; Kodet, Ondrej.
  • Dundr P; Institute of Pathology.
  • Simon K; Institute of Pathology.
  • Nemejcová K; Institute of Pathology.
  • Bártu M; Institute of Pathology.
  • Tichá I; Institute of Pathology.
  • Michálková R; Institute of Pathology.
  • Jaksa R; Institute of Pathology.
  • Vecková Z; Institute of Pathology.
  • Kodet O; Department of Dermatology and Venereology, First Faculty of Medicine, Charles University and General University Hospital in Prague.
Melanoma Res ; 29(2): 157-162, 2019 04.
Article en En | MEDLINE | ID: mdl-30422880
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Biomarcadores de Tumor / Estatmina / Melanocitos / Melanoma Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Biomarcadores de Tumor / Estatmina / Melanocitos / Melanoma Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article